Clinical Trials
3
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 1
1 (33.3%)A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects
Phase 2
Withdrawn
- Conditions
- Human Immunodeficiency Virus Infection
- Interventions
- First Posted Date
- 2012-11-30
- Last Posted Date
- 2013-03-29
- Lead Sponsor
- RFS Pharma, LLC
- Registration Number
- NCT01738555
A Safety and Efficacy Study of Amdoxovir in HIV-1 Treatment-experienced Subjects.
Phase 2
Terminated
- Conditions
- Human Immunodeficiency Virus Infection
- Interventions
- First Posted Date
- 2012-11-29
- Last Posted Date
- 2014-11-05
- Lead Sponsor
- RFS Pharma, LLC
- Target Recruit Count
- 2
- Registration Number
- NCT01737359
- Locations
- 🇦🇷
Research Site, Buenos Aires, Argentina
Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIV
Phase 1
Completed
- Conditions
- HIV Infections
- First Posted Date
- 2007-02-06
- Last Posted Date
- 2007-05-11
- Lead Sponsor
- RFS Pharma, LLC
- Target Recruit Count
- 24
- Registration Number
- NCT00432016
- Locations
- 🇦🇷
Hospital Privado Modelo, Buenos Aires, Argentina
News
No news found